Advertisement
News
Advertisement

Stemgent rakes in $11M, largest round to date

Mon, 08/13/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Cambridge stem cell research company Stemgent Inc. has taken $11.3 million in equity, the largest round to date for the four-and-a-half year old company, according to federal filings.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading